Comparison between Evans Electric IPO and Par Drugs IPO.
Evans Electric IPO is a SME Fixed Price IPO proposed to list at BSE SME while Par Drugs IPO is a SME Fixed Price proposed to list at NSE SME.
| Evans Electric IPO | Par Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Hem Securities Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Hem Securities Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Evans Electric IPO is up to ₹1.83 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.10 Cr. The final issue price of Evans Electric IPO is ₹52.00 per share and of Par Drugs IPO is ₹51.00 per share.
| Evans Electric IPO | Par Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹52.00 per share | ₹51.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 2000 shares | 2000 shares |
| Fresh Issue Size | 3,52,000 shares | 15,88,000 shares |
| Fresh Issue Size (Amount) | up to ₹1.83 Cr | up to ₹8.10 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 3,52,000 shares | 15,88,000 shares |
| Issue Size Total (Amount) | up to ₹1.83 Cr | up to ₹8.10 Cr |
Evans Electric IPO opens on Apr 30, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Evans Electric IPO and Par Drugs IPO is May 03, 2019, and May 08, 2019, respectively.
| Evans Electric IPO | Par Drugs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 30, 2019 | May 03, 2019 |
| Issue Close | May 03, 2019 | May 08, 2019 |
| Basis Of Allotment (Tentative) | May 08, 2019 | May 13, 2019 |
| Initiation of Refunds (Tentative) | May 09, 2019 | May 14, 2019 |
| Credit of Share (Tentative) | May 10, 2019 | May 15, 2019 |
| Listing date (Tentative) | May 13, 2019 | May 16, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Evans Electric IPO P/E ratio is , as compared to Par Drugs IPO P/E ratio of .
| Evans Electric IPO | Par Drugs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 80 | 99.55 | ||||
| Promoter Shareholding (Post-Issue) | 58.31 | 72.82 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹7.13 Cr. | ₹31.38 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Evans Electric IPO Retail Individual Investors (RII) are offered 1,76,000 shares while in Par Drugs IPO retail investors are offered 1,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Evans Electric IPO and in Par Drugs IPO.
| Evans Electric IPO | Par Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 20,000 shares | 84,000 shares |
| QIB | ||
| NII | 1,76,000 shares | 7,78,000 shares |
| RII | 1,76,000 shares | 7,80,000 shares |
| Employee | 30,000 shares | |
| Others | ||
| Total | 3,52,000 shares | 15,88,000 shares |
Evans Electric IPO subscribed 1.59x in total, whereas Par Drugs IPO subscribed 5.64x.
| Evans Electric IPO | Par Drugs IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.62x | 3.48x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.56x | 7.97x |
| Employee (times) | 1.00x | |
| Other (times) | ||
| Total (times) | 1.59x | 5.64x |
